Loading…
XYLOCAINE is a brand name for Lidocaine (also known as Lignocaine), supplied as a ointment. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: XYLOCAINE Ointment 5% (lidocaine) is indicated for: Temporary relief of pain associated with minor burns and abrasions of the skin, e.g. sunburn, herpes zoster and labialis, pruritus, sore nipples, insect bites; Anesthesia of mucous membranes, e.g. various anal conditions such as hemorrhoids and fissures; The…
Verbatim from this product's HC label. Tap a section to expand.
, Special Populations).
Pediatrics (<2 years of age):
Lidocaine should be used with caution in children younger than two years of age as there are insufficient data to support the safety and efficacy of this product in this patient population at this time. 3 WARNINGS AND PRECAUTIONS, Special Populations).
2 Geriatrics Geriatrics (> 65 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. Elderly patients should be given reduced doses commensurate with their age and physical condition as they may be more sensitive to systemic effects due to increased blood levels of lidocaine following repeated doses and may require dose reductions.
4 WARNINGS AND PRECAUTIONS, Special Populations). 2 CONTRAINDICATIONS Lidocaine is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
For a complete listing, see
and 7 WARNINGS AND PRECAUTIONS). , toxic effects) may occur with lidocaine and other local anesthetics or structurally related drugs, and Class I and Class III antiarrhythmic drugs due to additive effects (see
, Special Populations). 2 Geriatrics Geriatrics (> 65 years of age): Evidence from clinical studies and experience suggests that use in the geriatric population is associated with differences in safety or effectiveness. Elderly patients should be given reduced doses commensurate with their age and physical condition as they may be more sensitive to systemic effects due to increased blood levels of lidocaine following repeated doses and may require dose reductions.
4 WARNINGS AND PRECAUTIONS, Special Populations). 2 CONTRAINDICATIONS Lidocaine is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of the ointment (see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING).
Lidocaine is contraindicated in patients with congenital or idiopathic methemoglobinemia. , sulfonamides and are 12 months of age or younger (see 9 DRUG INTERACTIONS). 1 Dosing Considerations When XYLOCAINE Ointment 5% (lidocaine) is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind.
2 Recommended Dose and Dosage Adjustment Maximum Dosage Adults No more than 2 g (100 mg lidocaine base) in a single dose for endotracheal intubation. No more than 10 g (500 mg lidocaine base) in a single dose for other indications. After a maximum endotracheal dose or application to mucous membranes the next dose should not be applied until 4 hours later.
After a maximal dose given rectally or to burns the minimum dosing interval should be 8 hours. The total maximum dose administered in a 24-hour period to healthy adults should not exceed 20 g (1000 mg lidocaine base). Children XYLOCAINE Ointment 5% should be used with caution in children under the age of 2 as there is insufficient data to support the safety and efficacy of this product in this patient population at this time.
Lidocaine is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.
Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of the ointment (see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING). Lidocaine is contraindicated in patients with congenital or idiopathic methemoglobinemia.
, sulfonamides and are 12 months of age or younger (see 9 DRUG INTERACTIONS).
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Lidocaine in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
, methemoglobinemia). 2-11 Years It is difficult to recommend a maximum dose of any drug for children since this varies as a function of age and weight. 1 g ointment/kg body weight (corresponding to 5 mg lidocaine/kg of body weight).
The minimum dosing interval in children should be 8 hours. XYLOCAINE® Ointment (lidocaine) Page 6 of 26 12-18 Years For children over 12 years of age doses should be commensurate with weight and physical condition. 1 Special Populations Debilitated, elderly patients, acutely ill patients, patients with sepsis, and children should be given reduced doses commensurate with their age, weight and physical condition because they may be more sensitive to systemic effects due to increased blood levels of lidocaine following repeated doses.
3 Administration The ointment should be applied in a thin layer for adequate control of symptoms. A sterile gauze pad is recommended for application to broken and burned tissue. For sore nipples, apply on a small piece of gauze; the ointment must be washed away before the next feeding.
For endotracheal intubation, apply 1-2 g of ointment to the tube prior to intubation. 5 OVERDOSAGE Acute systemic toxicity from local anesthetics is generally related to high plasma levels encountered during therapeutic use of local anesthetics and originates mainly in the central nervous and the cardiovascular systems (see